Richard R. Fabian was named President of Profound Medical Corp. As of November 6, 2026, Profound Medical Corp. has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from August 17, 2026 to September 3, 2026, naming 2 appointments and 1 departure (Form 8-K, September 3, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Profound Medical Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Profound Medical Corp. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-08-17 to 2026-09-03. They name 3 people, with 2 appointments and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Profound Medical Corp. files it.
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-09-03 | In | President | 8-K, 2026-09-03 | ||
| 2026-08-17 | In | Chief Financial Officer | 8-K, 2026-08-17 | ||
| 2026-08-17 | Out | Chief Financial Officer | 8-K, 2026-08-17 |
Selling to them or working with them? See who runs Profound Medical Corp. now and the warning signs.
Free to see. No signup.
Watch Profound Medical Corp.
Get an email when Profound Medical Corp. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Profound Medical Corp.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Profound Medical Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Profound Medical Corp. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
2 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Who leads Profound Medical Corp., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- President: Richard R. Fabian, appointed (filed 2026-09-03).
- Chief Financial Officer: Matthew Sobczyk, appointed (filed 2026-08-17).
New leaders reset buying decisions — get the Full Report on Profound Medical Corp.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the President at Profound Medical Corp., with the record behind each one.
Find candidates like President at Profound Medical Corp.Every change, in the filing's words
Appointed: Richard R. Fabian, President
On September 1, 2026, Profound Medical Corp. (the "Company" or "Profound Medical") announced that Richard R. Fabian has been appointed by the Board of Directors of the Company (the "Board") to serve as the President of the Company, effective as of the same date (the "Appointment Date").
- Mr. Fabian succeeds Mathieu Burtnyk, PhD, who has shifted to the newly created position of Chief Technology Officer, effective as of September 1, 2026.
- Richard R. Fabian, age 59, served as President and CEO of FUJIFILM Sonosite, Inc. from 2017 to June 2026, where he oversaw the global Point of Care Ultrasound (POCUS) business.
- From 2002 to 2016, he held various executive leadership roles in marketing, sales, and global general management for the imaging and imaging guided therapy businesses at Philips Healthcare.
- Earlier in his career, he held positions in finance where he was a group controller at STERIS Corporation before he pivoted into operations and served as Vice President of Operations.
- Mr. Fabian holds a Bachelor of Arts degree in Economics from the University of Michigan and an MBA from the University of Pittsburgh Katz Graduate School of Business.
- Under the Employment Agreement, Mr. Fabian will receive an annualized base salary of $550,000.
- Mr. Fabian is eligible to receive an annual discretionary bonus of up to 100% of his base salary.
- During Mr. Fabian's initial 12-month period of employment, the Company will lease a residence in Toronto, Canada for Mr. Fabian's use while he spends approximately 50% of his time at the Company's Toronto office.
- The Company will also provide Mr. Fabian with a monthly car allowance of $1,000.
Appointed: Matthew Sobczyk, Chief Financial Officer
On August 14, 2026, Profound Medical Corp. (the "Company" or "Profound Medical") announced that Matthew Sobczyk has been appointed by the Board of Directors of the Company (the "Board") to serve as the Interim Chief Financial Officer of the Company, effective as of the same date (the "Appointment Date").
Departing: Rashed Dewan, Chief Financial Officer
Separation Agreement and Contractor Services Agreement On August 14, 2026, Rashed Dewan resigned from his position as Chief Financial Officer of the Company, effective the same day (the "Separation Date").
- Matthew Sobczyk, CPA, CA, age 42, has served in progressively senior financial leadership roles at the Company since May 2017.
- From March 2023 to August 2026, Mr. Sobczyk served as Corporate Controller of the Company.
- Prior to that role, he served as Assistant Corporate Controller of the Company from March 2021 to March 2023, and as Manager, Accounting & Reporting of the Company from May 2017 to March 2021.
- Prior to joining Profound Medical, Mr. Sobczyk spent over a decade in public accounting, audit, and advisory roles with Ernst & Young LLP and MNP LLP.
- Mr. Sobczyk holds a Bachelor of Arts (Honours Business Administration) from the Richard Ivey School of Business at Western University and earned his Chartered Professional Accountant, Chartered Accountant (CPA, CA) designation in Ontario.
- Mr. Sobczyk is eligible to receive an annual discretionary bonus with a target of 15% of his base salary.
- The Separation Agreement also includes a release and waiver by Mr. Dewan and other customary provisions.
- In addition, the Company and Mr. Dewan entered into a Contractor Services Agreement, dated August 14, 2026 (the "Contractor Services Agreement"), pursuant to which Mr. Dewan will provide transition and advisory services to the Company as an independent contractor for the period commencing August 17, 2026 through November 25, 2026.
Tools for this story
Each opens in a new tab, filled in for Profound Medical Corp.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.